Subversive Acquisition LP Provides Update on Qualifying Transaction With InterCure, Israel’s Leading and Fastest-Growing Cannabis Company
Subversive Acquisition LP Has Met All Conditions of Closing and Expects to Close on or Before Friday April 23, 2021
SPAC Restricted Voting Units Currently Trade on the TSX Under the Symbol “SVX.U” and the OTCQX Under the Symbol “SBVRF”
On Closing Common Shares of InterCure will Trade on the TSX Under the Symbol “INCR.U” and the TASE Under the Symbol “INCR”
Listing of InterCure’s Shares on NASDAQ Expected in Q2 2021 and Trade Under the Symbol “INCR”
NEW YORK and TORONTO and HERZLIYA, Israel, April 21, 2021 (GLOBE NEWSWIRE) Subversive Acquisition LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) a special purpose acquisition company (SPAC), today announced it has met all conditions of closing, with the exception for the closing condition that will be met upon InterCure’s shares trading on the TSX, for its qualify
Subversive Acquisition LP Provides Update on Qualifying Transaction
Nachrichtenquelle: globenewswire | 11.04.2021, 03:58 | 57
SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“
SVX”) announced today that closing of its qualifying transaction to combine with InterCure Ltd. (dba Canndoc) (TASE: INCR), Israel’s leading cannabis company, is expected to occur as soon as practicable after the outstanding conditions to closing are met, which SVX expects to be on or before April 20, 2021.
About SVX Subversive Acquisition LP is a limited partnership established under the Limited Partnerships Act (Ontario) formed for the purpose of effecting, directly or indirectly, an acquisition of one or more businesses or assets, by way of a merger, amalgamation, arrangement, equity exchange, asset acquisition, equity purchase, reorganization, or any other similar business combination involvi
Subversive Acquisition LP Announces Extension of Permitted Timeline for Completion of Its Qualifying Transaction
TORONTO, April 08, 2021 (GLOBE NEWSWIRE)
SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“
SVX”) announced today that the date by which SVX has to consummate its qualifying transaction is extended to August 31, 2021 (the “
Extension”).
On January 26, 2021, SVX announced its qualifying transaction to combine with InterCure Ltd. (dba Canndoc) (TASE: INCR), Israel’s leading cannabis company (the “
Business Combination”). Canndoc, a wholly owned subsidiary of InterCure Ltd., is Israel’s largest licensed cannabis producer.
On April 6, 2021, unitholders approved the Business Combination, with over 89.36% of the votes cast in favour of the plan of arrangement (the “
Subversive Acquisition LP Announces InterCure’s Agreement With Cookies to Expand the Iconic Cannabis Brand Across Europe Cookies Partnership Supports InterCure’s Growth and European Expansion Strategy
April 06, 2021 09:23 ET | Source: Subversive Acquisition LP Subversive Acquisition LP
TORONTO, April 06, 2021 (GLOBE NEWSWIRE)
SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“
SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“
InterCure”), Israel’s leading cannabis company and SVX’s intended target for its “Qualifying Transaction” (the “
Transaction”), has signed a letter of intent with iconic cannabis brand Cookies for its European expansion. InterCure will work with Cookies to replicate the success achieved by Cookies in the United States and Israel.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Subversive Acquisition LP Announces InterCure’s Agreement With Cookies to Expand the Iconic .
Subversive Acquisition LPApril 6, 2021 GMT
TORONTO, April 06, 2021 (GLOBE NEWSWIRE) SUBVERSIVE ACQUISITION LP (TSX: SVX.U, NEO: SVX.U, OTCQX: SBVRF) (“SVX”) announced today that InterCure Ltd. (dba Canndoc) (TASE: INCR) (“InterCure”), Israel’s leading cannabis company and SVX’s intended target for its “Qualifying Transaction” (the “Transaction”), has signed a letter of intent with iconic cannabis brand Cookies for its European expansion. InterCure will work with Cookies to replicate the success achieved by Cookies in the United States and Israel.